ICMH
EFTRW

Integrity Capital Management (HK)’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Integrity Capital Management (HK)’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-66,181
Closed -$58K – 242
2021
Q4 		$58K Buy
+66,181
New +$83.2K 0.18% 96

Other funds holding EFTRW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
ICM
III Capital Management Boca Raton, Florida $344M AUM 11.22% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Integrity Capital Management (HK)'s EFTRW Position: Q1 2022 in Review

Integrity Capital Management (HK) sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q1 2022, closing a stake of 66,181 shares — an estimated $58K sold.

Integrity Capital Management (HK) first reported a position in EFTRW in Q4 2021 and held it in 1 quarter. The position peaked at $58K in Q4 2021. 17 funds tracked by Wall St. Rank hold EFTRW as of Q1 2022.

  • Integrity Capital Management (HK) reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
  • Integrity Capital Management (HK) sold 66,181 eFFECTOR Therapeutics, Inc. Warrant shares in Q1 2022, an estimated $58K.
  • Integrity Capital Management (HK) first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q4 2021 and held it in 1 quarter.
  • Integrity Capital Management (HK)'s eFFECTOR Therapeutics, Inc. Warrant position peaked at $58K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q1 2022.

Based on Integrity Capital Management (HK)'s 13F filing for Q1 2022, filed 26 Apr 2022.